Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of a New Catheter Material for Intermittent Catheterization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent~* Males, aged 18 years and over~* Maintained urethra sensibility~* Practice intermittent self-catheterization at least 2 times daily~* Using catheters in the length of 40 cm and size charrière (Ch) 12 or Ch 14~* Experienced practitioners of intermittent self-catheterization defined as a minimum of three months on therapy~* Experience of using LoFric catheter within the last 12 months prior to study entry~* Adults able to read, write and understand information given to them regarding the study~Exclusion Criteria:~* Ongoing, symptomatic urinary tract infection (UTI) at enrolment as judged by investigator~* Known urethral stricture at enrolment as judged by investigator~* Involvement in the planning and/or conduct of the study (applies to both Astra Tech staff or staff at the study site)~* Previous enrolment or randomisation of treatment in the present study

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LoFric POBE 2.0 - PVC (Type: EXPERIMENTAL): First period (7 days) use of LoFric POBE 2.0 followed by second period (7 days) use of LoFric PVC
- LoFric PVC - POBE 2.0 (Type: EXPERIMENTAL): First period (7 days) use of LoFric PVC followed by second period (7 days) use of LoFric POBE 2.0.

Based on this trial design, predict the completion outcome and termination type (if applicable).